NCT03385525View on ClinicalTrials.gov

Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 12, 2017

Primary Completion Date

October 13, 2017

Study Completion Date

October 13, 2017

Conditions
Drug Interaction
Interventions
DRUG

BIIB074

Administered as specified in the treatment arm

DRUG

Valproic Acid

Administered as specified in the treatment arm

Trial Locations (1)

75247

Research Site, Dallas

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY